MEDICINA
Departamento
University of Cincinnati
Cincinnati, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Cincinnati (2)
2022
-
Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5
Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 9, pp. 2367-2374.e3
2021
-
Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19
New England Journal of Medicine, Vol. 385, Núm. 9, pp. 790-802